Clinical trial

Evaluation of the Tantalus System in Type 2 Diabetic Subjects

NCT00276471 · MetaCure Limited, Industry · Completed

Key facts

NCT number NCT00276471
Title Evaluation of the Tantalus System in Type 2 Diabetic Subjects
Official title Evaluation of the Tantalus System in Type 2 Diabetic Subjects
Lead sponsor MetaCure Limited, Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions Type 2 Diabetes, Obesity
Intervention type Device
Interventions Implantable pulse generator and electrodes
Enrollment 18
Start date Dec 1, 2005
Primary completion Jan 1, 2007
Completion Jun 1, 2007
First posted Jan 13, 2006
Last update posted Feb 2, 2012
Countries Austria

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies